Suspected high-dose MDMA pills tested by KnowYourStuffNZ 2018/2019 season

KnowYourStuffNZ has found pills containing potentially dangerous high doses of MDMA during the 2018/2019 festival season. These pills were found at events throughout New Zealand.

They should be approached with caution. Users are advised that the only way to guarantee safety is to not take them. For those who do choose to take them, our recommendation is to only take a third of a pill at most, and wait at least an hour before considering taking any more.

These pills have been tested to contain MDMA and a variety of fillers. No other psychoactives have been detected in these, despite anecdotal reports that they also contain ketamine.

A common dose of MDMA is around 80-120 milligrams, depending upon a user’s body weight. Some of the pills that KnowYourStuffNZ have tested this summer contained up to four doses in one pill.

Taking too much MDMA can result in a very unpleasant experience, health risks, and sometimes even death. If you or someone you know has taken one of these pills and experiences dizziness and vomiting, a sharp rise in body temperature, muscle cramping, heart palpitations, seizures, or unconsciousness, seek medical attention immediately.

Please note that the amount of MDMA present is an estimate only as our technology cannot directly measure dosage or purity. The spectrometer can provide a rough percentage of MDMA content in a sample and we use this combined with the weight of the pill to reach these estimates. The estimated dosage should be treated as an indication only and we recommend always erring on the side of caution.

Suspected high dose pills include:

Purple Defqon

Purple/pink, round, logo of Defqon festival one side only

Weight: 320mg

Estimated to contain 150-200mg MDMA

Defqon IMG_20190222_164253 balanced sheared

Colour and size reference chart
(1 square= 1cm2)
Pink Porsche

Bright pink, shield shape, Porsche logo one side

Weight: 350mg

Estimated to contain 200-250mg MDMA

PP example pic
Pink Maple Leaf

Pink, Canadian maple leaf shape, ‘D2’ on one side, ‘ICON’ on the other

Weight: 330mg

Estimated to contain 200-300mg MDMA

Pink Maple leaf Icon side - Copy

Pink Maple leaf D2 side - Copy

Yellow Rolex

Bright yellow, Rolex crown logo shape, crown stamp one side

Weight: 350mg

Estimated to contain 200-300mg MDMA

No photo available
Green/grey Skull

Green and/or grey, unusual cylindrical shape, skull stamped on one end, crown on the other

Weight: 600mg

Estimated to contain 400mg MDMA

No photo available
Purple Tomorrowland

Purple pill, Tomorrowland logo

Weight: 470mg

Estimated to contain 200-300mg MDMA

No photo available
Grey Pharaoh

Blue/grey/purple, (shape?), Egyptian head on one side, “Warning, 240mg” on other.

Weight: 500mg

Estimated to contain 200-300mg MDMA

No photo available
Blue or Yellow Visa

Blue or yellow  pill, rectangular with rounded edges, Visa logo

Reported as high dose but no weight or content estimate available. Approach with caution.

No photo available

KnowYourStuffNZ is a not-for-profit social enterprise funded entirely by donations from the community. If you value our work, please donate.

ALERT: Blue pills containing n-ethylpentylone and MDMA

cropped-knowyourstuffnz-logo-june-2017.png

N-ethylpentylone found in pills obtained as MDMA

KnowYourStuffNZ tested pills over the New Year and found a particularly dangerous substance mixed with MDMA. Five pills from separate sources were tested and all were found to contain low amounts of MDMA and potentially dangerous levels of n-ethylpentylone.

N-ethylpentylone is a stimulant from the cathinone family, also called “bath salts”. It may produce short-lived euphoria followed by a long period of overstimulation including racing heart, high blood pressure, anxiety, overheating, and inability to sleep for up to 36 hours.  In large doses it has been associated with deaths overseas and hospitalisations in New Zealand. Because of the high redose compulsion and low active dose, it is very easy to overdose. You can read more about n-ethylpentylone at our website.

The identified pills are pale blue and round with slight speckling and a four-pointed crown stamped on one side.  

MDMA NEP NYE 2018

When tested with Marquis and Mandelin reagents they show the black colour change associated with MDMA. Testing with the more reliable FT-IR spectroscopy has confirmed these pills also contain high levels of n-ethylpentylone. The amount of n-ethylpentylone present may vary between pills. Users of single pills have reported anxiety and unpleasant experiences which may be potentially dangerous.

REAGENT TESTING WILL NOT REVEAL THIS ADULTERATION.

It is likely that these pills have spread throughout New Zealand, therefore any substance that looks like this should be treated as dangerous regardless of your location.  

N-ethylpentylone was also detected in powders and crystals of various colours. In total, approximately 15% of “MDMA” tested over New Years was found to contain n-ethylpentylone. Please approach all untested substances with extreme caution:

  • safest of all, do not take it
  • if consuming, start small, start slow – take a third or less, and wait at least an hour before having more
  • do not snort or inject
  • do not mix with other substances, including alcohol
  • do not take alone

If you think you may have inadvertently consumed n-ethylpentylone and are concerned, please contact your nearest medical service and be honest about what you believe you have taken.  

KnowYourStuffNZ is a not-for-profit social enterprise funded entirely by donations from the community. If you value our work, please donate.

 

Fentanyl found at New Zealand festival

Testing by KnowYourStuffNZ has identified a sample containing Fentanyl, a drug which has killed a significant number of people in the United States, United Kingdom, and Canada in the last two years.

We began testing for Fentanyl this summer after observing the rise in Fentanyl use in other countries and becoming aware that it was being detected at the New Zealand border by Customs. This is the first time it has been identified as a contaminant in New Zealand’s illicit market.

The sample was found in February as a white powder presumed to be heroin. Both heroin and Fentanyl are opioids, however Fentanyl is considerably more toxic and is more likely to lead to overdose. Fentanyl suppresses breathing at a much smaller quantity than other opioids. The risk of death is higher than other opioids, and further increased when unknowingly consumed as a substitute or adulterant in other drugs.

We strongly recommend that users of opioids do not take Fentanyl. Any opioid should be tested for Fentanyl contamination before use.

The most reliable testing method is the Fentanyl testing strip. These can detect small amounts of Fentanyl and analogues, are simple to use, and are available from Hempstore.

20180224_110833 white balanced.jpg
Test strip showing a positive finding of Fentanyl

KnowYourStuffNZ recommends the Government takes three immediate steps to reduce the risk  from Fentanyl by committing to:

  • Updating the Misuse of Drugs Act to empower DHBs and other drug health services to provide forensic drug checking in New Zealand cities, allowing people to identify if their substance is not what they expected. For example, testing by KnowYourStuffNZ in January identified n-ethylpentylone being sold as MDMA. February’s mass hospitalisation in Christchurch due to n-ethylpentylone could have been prevented had such a service been widely available.
  • Facilitating the distribution of emergency overdose kits containing Naloxone, a very effective antidote to opioid overdose, to users of opioid drugs and their loved ones. Naloxone is affordable, easy to use, and legal as part of an approved emergency overdose kit. However an emergency kit has yet to be assembled or approved by the government. As yet Naloxone is only available on prescription through paramedics or emergency departments at hospitals. Most overdoses happen in front of other people and deaths are avoidable if Naloxone is readily available.
  • Implementing an effective drug Early Warning System. KnowYourStuffNZ’s discovery of Fentanyl as a substitute in the illicit market demonstrates that the risks from new substances can be foreseen and reduced. In contrast, the mass hospitalisation incident in Christchurch and the 20 deaths associated with AMB-FUBINACA last year, show the damage that occurs without a warning system.

Agencies such as Customs, ESR, Police, and emergency departments collect data on emerging drugs, but the information is not shared with the people most likely to be affected – the public of New Zealand. KnowYourStuffNZ is the only group currently informing the public about substances of concern. We should not have to wait until there is a death from inadvertent Fentanyl ingestion for an Early Warning System to be a priority.

KnowYourStuffNZ recommends a multi-agency, collaborative approach using existing models adopted from effective systems overseas. In the interim KnowYourStuffNZ will continue to provide information about identified substances of concern. As always, everyone should be aware that without testing, all substances are unknown substances. Test before you ingest.

KnowYourStuffNZ is a not-for-profit social enterprise funded entirely by donations from the community. If you value our work, please donate.

“Faulty batch” warning not helpful

A warning has been released by Canterbury DHB after 9 people presented at Christchurch hospital Saturday night.

Unfortunately it appears that the DHB is speculating about what the people had taken in the absence of knowing for certain, and have released a vague warning about a ‘faulty batch’. There is no such thing as a faulty batch.

KnowYourStuffNZ in its testing of ‘MDMA’ this year has found:

Any of these would have associated potential dangers, but none of them are a ‘faulty batch of MDMA’.

The information in the alert is of almost no use to users. The warning contains no mention that the substance could be something completely different, no description of the substance, and no information about what sort of symptoms a user may experience that would signify danger. This warning might as well say “Don’t take MDMA.” Such an approach has been entirely ineffective at stopping people taking MDMA to date.

This is why New Zealand needs a properly-functioning Early Warning System, with protocols for what an effective, harm-reduction-focused warning looks like. At the very least, a warning should contain:

  • a description of the substance so users know what to avoid
  • information about the content of the substance – if this is not known, that should be made clear and warnings should refrain from speculation
  • information about symptoms that signal danger.

We have released four alerts about substances of concern since the beginning of 2018. Right now, we are NZ’s Early Warning System. This is not good enough. The NZ government has been talking for years about implementing one, but the talk has not resulted in action. Warnings are left to DHBs with limited knowledge of illicit drugs and harm reduction, and community groups such as ourselves.

The government needs to step up and progress the national Early Warning System immediately. Meanwhile, we will continue to release information about substances of concern as they arise.

On the topic of the Christchurch mystery drug, our advice is:

  • Approach all unknown substances with extreme caution.
  • Unless they have been tested and confirmed to contain the desired substance and only the desired substance, they are *all* unknown.
  • Substitution, adulteration, and extremely high dose pills are all currently being found in the market.
  • When using, it is much better to take a fraction of a dose and await developments (at least an hour) than to take the whole thing without knowing what it is and risk a trip to the hospital.

Be careful out there, folks.

[EDIT: Three weeks after thirteen people were hospitalised in Christchurch after ingesting this mystery substance, NZ Police confirmed that the substance was n-ethylpentylone. We published our warning about this substance two weeks before this event and five weeks before the Police. This shows that KnowYourStuffNZ is already acting as New Zealand’s drug early warning system. However, we are constrained by the legal grey area that we operate in. Clarifying the law and allowing us to operate openly will save lives.]

KnowYourStuffNZ is a not-for-profit social enterprise funded entirely by donations from the community. If you value our work, please donate.

Today’s message is short and simple – test your GHB.

We are aware that GHB (Gamma Hydroxybutyrate) is used recreationally at events, even though it’s not often brought to KnowYourStuffNZ for testing. It’s one of the substances that people think doesn’t need testing because it comes in an easily recognisable format. However, all of the samples brought to us as GHB this summer have turned out to be GBL (gamma-Butyrolactone).

GBL is chemically very similar to GHB and converts to GHB quickly once it enters the body. However it’s also two to three times stronger, making the amount required to overdose much lower. The amount that will cause an overdose is also bodyweight dependent, which means taking a GHB-sized dose of GBL can easily lead to overdose and death – especially for smaller people. Adding other drugs increases the risk. Alcohol is especially dangerous to combine with GHB or GBL.

It’s important to know whether you have GHB or GBL before ingesting – please test it first.  If you done have access to KnowYourStuffNZ’s testing service, test kits can be purchased here. Avoid combining it with alcohol, other depressants, stimulants, or dissociatives. As ever, know what you are taking and research the risks.

KnowYourStuffNZ is a not-for-profit social enterprise funded entirely by donations from the community. If you value our work, please donate.

Know Your Stuff-29